Showing 1 - 2 results of 2 for search 'Matthieu Gassiot', query time: 0.02s Refine Results
  1. 1
    A first‐in‐human, single and multiple dose study of lunsekimig, a novel anti‐TSLP/anti‐IL‐13 NANOBODY® compound, in healthy volunteers

    A first‐in‐human, single and multiple dose study of lunsekimig, a novel anti‐TSLP/anti‐IL‐13 NANOBODY® compound, in healthy volunteers by Annemie Deiteren, Lieselot Bontinck, Griet Conickx, Marie Vigan, Nele Dervaux, Matthieu Gassiot, Selcuk Bas, Benjamin Suratt, Heribert Staudinger, Emmanuel Krupka

    Published 2024-06-01
    Get full text
    Article
  2. 2
    The Anti-Cancer Drug Dabrafenib Is a Potent Activator of the Human Pregnane X Receptor

    The Anti-Cancer Drug Dabrafenib Is a Potent Activator of the Human Pregnane X Receptor by Nicolas Creusot, Matthieu Gassiot, Elina Alaterre, Barbara Chiavarina, Marina Grimaldi, Abdelhay Boulahtouf, Lucia Toporova, Sabine Gerbal-Chaloin, Martine Daujat-Chavanieu, Alice Matheux, Roger Rahmani, Céline Gongora, Alexandre Evrard, Philippe Pourquier, Patrick Balaguer

    Published 2020-07-01
    Get full text
    Article

Search Tools: